What dose of insulin glargine (Lantus) should be administered to a 15‑lb (≈6.8‑kg) diabetic dog?

Insulin Glargine Dosing for a 15-lb (6.8-kg) Diabetic Dog

For a 15-lb (6.8-kg) diabetic dog, start insulin glargine (Lantus) at 0.3 U/kg subcutaneously every 12 hours, which equals approximately 2 units per injection (total daily dose of 4 units). This conservative starting dose minimizes hypoglycemia risk while establishing baseline insulin requirements.

Initial Dosing Strategy

The veterinary literature consistently demonstrates that dogs require twice-daily insulin glargine administration for optimal glycemic control, despite glargine's 24-hour duration in humans 1, 2. In the largest prospective veterinary study, only 6% of dogs achieved adequate control with once-daily dosing 1.

Starting dose calculation for your 6.8-kg dog:

• Use 0.3 U/kg as the initial dose (conservative approach for newly diagnosed or insulin-naive dogs) 1
• 6.8 kg × 0.3 U/kg = 2.04 units per injection
• Round to 2 units subcutaneously every 12 hours
• Total daily dose: 4 units

Dosing Rationale and Evidence Hierarchy

The human FDA label recommends 0.2 U/kg for type 2 diabetes 3, but canine physiology differs significantly. Dogs metabolize insulin glargine faster and demonstrate peak effects at 2-6 hours rather than the peakless profile seen in humans 1, 4.

Key veterinary evidence:

• A 2013 study of 10 diabetic dogs found mean effective dose of 0.5 U/kg twice daily (range 0.32-0.67 U/kg) 1
• Starting at 0.3 U/kg minimizes hypoglycemia during initial titration
• 87% of dogs receiving high doses (>1.5 U/kg) in one study were on once-daily regimens and had poor control 5

Titration Protocol

Monitor blood glucose every 2-4 hours for the first 10-12 hours after initial dosing. Adjust dose based on:

1. If minimum glucose >250 mg/dL: Increase by 10-20% (0.2-0.4 units for this dog)
2. If minimum glucose 150-250 mg/dL: Maintain current dose, reassess in 3-5 days
3. If glucose <80 mg/dL at any point: Reduce dose by 25-50% immediately

Target glucose range: 100-250 mg/dL throughout the day, with most readings 150-200 mg/dL.

Critical Monitoring Requirements

Continuous glucose monitoring (CGM) or flash glucose monitoring is essential for safe glargine titration in dogs 6. Blood glucose curves every 1-3 weeks during dose adjustment prevent dangerous hypoglycemia, which occurred in 70% of dogs in one study 1.

Warning signs requiring immediate dose reduction:

• Blood glucose <80 mg/dL
• Weakness, trembling, or seizures
• Excessive hunger followed by lethargy
• Ataxia or disorientation

Common Pitfalls to Avoid

1. Do not use once-daily dosing initially – 80% of hypoglycemic episodes in diabetic dogs occur with once-daily regimens 5

2. Do not start with high doses – Dogs receiving >1.5 U/kg had 87% incidence of poor control or hypoglycemia 5

3. Do not mix or dilute glargine – This alters pharmacokinetics unpredictably 3

4. Do not administer intravenously – Subcutaneous tissue injection is required for proper 12-hour duration 3

Expected Timeline to Glycemic Control

Most dogs achieve good diabetic control within 38 days (range 7-55 days) of starting glargine 1. Your 15-lb dog will likely require dose adjustments every 3-7 days during this period.

Final maintenance doses typically range:

• 0.4-0.7 U/kg twice daily (2.7-4.8 units per injection for your dog)
• Some dogs require up to 2.5 U/kg/day in divided doses 6

Alternative Considerations

If twice-daily dosing proves impractical, insulin glargine 300 U/mL (not the 100 U/mL Lantus formulation) may allow once-daily administration in 59% of dogs, though this requires 4-fold higher doses (median 1.9 U/kg once daily) 6. However, start with standard Lantus 100 U/mL twice daily as outlined above for predictable results.

The conservative 0.3 U/kg starting dose protects against the 6% incidence of clinical hypoglycemia reported even in controlled studies 6, while the twice-daily schedule addresses the shorter duration of action in canine patients compared to humans.